Surgical instruments, systems, and methods incorporating ultrasonic and electrosurgical functionality
A surgical system includes an ultrasonic blade operably coupled to an ultrasonic transducer, a jaw member pivotable relative to the blade for clamping tissue between the blade and the jaw member, and at least one controller. A portion of the jaw member is adapted to connect to a source of electrosurgical energy at a first potential and another portion of the jaw member or the blade is adapted to connect to the source of electrosurgical energy at a second potential to conduct electrosurgical energy therebetween and through the clamped tissue. The blade is configured to transmit ultrasonic energy to the tissue clamped between the blade and the jaw member. The at least one controller is configured to monitor a resonant frequency associated with the ultrasonic energy and to monitor an impedance of the clamped tissue associated with the electrosurgical energy and to determine whether an adverse condition exists based thereon.
1 . A surgical system, comprising:
an ultrasonic blade operably coupled to an ultrasonic transducer for receiving ultrasonic energy produced by the ultrasonic transducer;
a jaw member pivotable relative to the ultrasonic blade between a spaced-apart position and an approximated position for clamping tissue between the ultrasonic blade and the jaw member, wherein a portion of the jaw member is adapted to connect to a source of electrosurgical energy at a first potential and another portion of the jaw member or the ultrasonic blade is adapted to connect to the source of electrosurgical energy at a second potential different from the first potential to conduct electrosurgical energy therebetween and through the clamped tissue, and wherein the ultrasonic blade is configured to transmit ultrasonic energy to the tissue clamped between the ultrasonic blade and the jaw member; and
at least one controller configured to monitor a resonant frequency associated with the ultrasonic energy and to monitor an impedance of the clamped tissue associated with the electrosurgical energy and to determine whether an adverse condition exists based on the monitoring of the resonant frequency and the monitoring of the impedance of the clamped tissue, wherein the controller is configured to determine that an adverse condition exists when it is determined that an expected change in impedance did not occur and that an expected decrease in resonant frequency did not occur.
2 . The surgical system according to claim 1 , wherein the controller is further configured, in response to determining that the adverse condition exists, to provide an indication that the adverse condition exists.
3 . The surgical system according to claim 1 , wherein the controller is further configured, in response to determining that the adverse condition exists, to modify at least one of the ultrasonic energy or the electrosurgical energy.
4 . The surgical system according to claim 1 , wherein the controller is further configured, in response to determining that the adverse condition exists, to turn off at least one of the ultrasonic energy or the electrosurgical energy.
5 . The surgical system according to claim 1 , wherein the electrosurgical energy is configured to facilitate tissue treatment in conjunction with the ultrasonic energy.
6 . The surgical system according to claim 1 , wherein the ultrasonic energy is configured to treat tissue and the electrosurgical energy is configured to interrogate tissue.
7 . The surgical system according to claim 1 , wherein monitoring the resonant frequency includes monitoring at least one of: a value of the resonant frequency, a ramp of the resonant frequency, or a change in the resonant frequency.
8 . The surgical system according to claim 1 , wherein monitoring the impedance of the clamped tissue includes monitoring at least one of: a value of the impedance, a ramp of the impedance, or a change in the impedance.
9 . A method of energy-based tissue treatment, comprising:
transmitting ultrasonic energy, via an ultrasonic blade, to tissue clamped between the ultrasonic blade and a jaw member;
energizing a portion of the jaw member with electrosurgical energy at a first potential and energizing another portion of the jaw member or the ultrasonic blade with electrosurgical energy at a second potential different from the first potential to conduct electrosurgical energy therebetween and through the clamped tissue;
monitoring a resonant frequency associated with the ultrasonic energy;
monitoring an impedance of the clamped tissue associated with the electrosurgical energy; and
determining whether an adverse condition exists based on the monitoring of the resonant frequency and the monitoring of the impedance, wherein it is determined that an adverse condition exists when it is determined that an expected change in impedance did not occur and that an expected decrease in resonant frequency did not occur.
10 . The method according to claim 9 , further comprising, in response to determining that the adverse condition exists, providing an indication that the adverse condition exists.
11 . The method according to claim 9 , further comprising, in response to determining that the adverse condition exists, modifying at least one of the ultrasonic energy or the electrosurgical energy.
12 . The method according to claim 9 , further comprising, in response to determining that the adverse condition exists, turning off at least one of the ultrasonic energy or the electrosurgical energy.
13 . The method according to claim 9 , wherein the electrosurgical energy is configured to facilitate tissue treatment in conjunction with the ultrasonic energy.
14 . The method according to claim 9 , wherein the ultrasonic energy is configured to treat tissue and the electrosurgical energy is configured to interrogate tissue.
15 . The method according to claim 9 , wherein the monitoring of the resonant frequency includes monitoring at least one of: a value of the resonant frequency, a ramp of the resonant frequency, or a change in the resonant frequency.
16 . The method according to claim 9 , wherein the monitoring of the impedance includes monitoring at least one of: a value of the impedance, a ramp of the impedance, or a change in the impedance.
17 . A surgical system, comprising:
an ultrasonic blade operably coupled to an ultrasonic transducer for receiving ultrasonic energy produced by the ultrasonic transducer;
a jaw member pivotable relative to the ultrasonic blade between a spaced-apart position and an approximated position for clamping tissue between the ultrasonic blade and the jaw member, wherein a portion of the jaw member is adapted to connect to a source of electrosurgical energy at a first potential and another portion of the jaw member or the ultrasonic blade is adapted to connect to the source of electrosurgical energy at a second potential different from the first potential to conduct electrosurgical energy therebetween and through the clamped tissue, and wherein the ultrasonic blade is configured to transmit ultrasonic energy to the tissue clamped between the ultrasonic blade and the jaw member; and
at least one controller configured to monitor a resonant frequency associated with the ultrasonic energy and to monitor an impedance of the clamped tissue associated with the electrosurgical energy and to determine whether an adverse condition exists based on the monitoring of the resonant frequency and the monitoring of the impedance of the clamped tissue, wherein the controller is configured to determine that a wet field condition exists when it is determined that an expected change in impedance did not occur and that an expected decrease in resonant frequency did not occur.
18 . The surgical system according to claim 17 , wherein the expected change in impedance is an expected increase in impedance.
19 . The surgical system according to claim 17 , wherein the controller is further configured, in response to determining that the wet field condition exists, to turn off at least one of the ultrasonic energy or the electrosurgical energy.
20 . The surgical system according to claim 17 , wherein monitoring the impedance of the clamped tissue includes monitoring at least one of: a value of the impedance, a ramp of the impedance, or a change in the impedance.